Data Snapshot
UW Medicine Hospitals:
King County: The county reported 276 new positive cases and 0 new deaths on May 3.
Washington: The state reported 377,019 cases and 5,507 deaths as of May 2.
United States: The CDC reports 32,228,003 cases and 574,220 deaths as of May 3.
Global: WHO reports 153,187,889 confirmed COVID-19 cases and 3,209,109 deaths as of May 4.
Numbers update frequently, please follow links for most up-to-date numbers.
UW Medicine COVID-19 Vaccine Distribution Update
Total Vaccine Doses Administered: 263,995
- Total first dose: 144,324
- Total second dose: 119,671
As of May 2, 2021.
UW Medicine in the News
KOMO News: Health officials say we will likely need a booster shot for the COVID-19 vaccine
Featuring: Deborah Fuller, Microbiology
“As more people continue to get vaccinated, both Moderna and Pfizer are expecting people will need to get a booster shot roughly a year after they receive their second dose of the vaccine. ‘It would be nice to have a one and done and kiss this pandemic goodbye but it’s probably going to stick with us a little bit longer,’ said Deborah Fuller with UW Medicine. And according Fuller, a little longer could mean a few more years. It’s why these companies are making sure they are manufacturing booster shots of the vaccine, along with the first doses, to potentially administer in about a year’s time.”
KING 5: Yes, ‘COVID arm’ delayed side effect is real
Featuring: Paul Pottinger, Allergy & Infectious Diseases
“As thousands of people get the COVID-19 vaccine each day, a new but uncommon side effect has emerged among the vaccinated. Some are already calling it ‘COVID arm’ to describe a delayed side effect that includes redness and itchiness at the injection site that can resemble a rash. An article published in the New England Journal of Medicine this month reported, among the 30,420 participants in a clinical trial for the Moderna vaccine, 244 or 0.8% of the participants experienced COVID arm. The reactions showed up among 68 participants after the second dose. Dr. Paul Pottinger, a professor of medicine at the University of Washington’s Division of Allergy & Infectious Diseases, said his patients have reported similar side effects. ‘It’s very clearly a delayed, allergic-type of reaction to something in the vaccine and it’s benign, it goes away and it’s not a big deal,’ Pottinger said.”
MSN: What the Pacific Northwest COVID surge means for California
Featuring: Seth Cohen, Infectious Diseases
“While California is reopening, Gov. Brown, tightened restrictions this week, rolling back activities in Oregon like indoor dining. ‘While fewer seniors are being hospitalized thanks to vaccinations, COVID-19 is now knocking more younger people off their feet,’ she said. Brown said that in Oregon, hospitalized cases of people ages 18 to 34 have increased by almost 50%. It’s a similar story in Washington. ‘Young people who develop COVID and some of them have been admitted to the ICU, some of them have been on breathing machines, and it is just heartbreaking to watch,’ said Dr. Seth Cohen, director of infection prevention at University of Washington Medical Center in Seattle. Dr. Cohen says everyone hospitalized right now at UW is unvaccinated. ‘We’re still dealing with some of the Pacific Northwest weather which keeps people inside. But we’re also dealing with a lot of variants that are circulating in this area and it’s really been a race to get vaccines into people.’”
COVID-19 Literature Report
COVID-19 Literature Situation Report is a daily (M-F) newsletter put together by the Alliance for Pandemic Preparedness that provides a succinct summary of the latest scientific literature related to the COVID-19 pandemic.
Key Takeaways: COVID-19 Literature Situation Report April 30, 2021
- Patients with severe COVID-19 who received the anti-inflammatory medication tocilizumab were more likely to be discharged from the hospital (57% vs. 50%) and less likely to die (31% vs. 35%) in a randomized trial. More.
- A large, national survey of US adults (N=2,142,887) found an association between living with a child who attended in-person school and the risk of COVID-19-associated outcomes (OR=1.4), although this association did not persist when ≥7 in-school low-cost, common mitigation measures such as mask mandates were reported. More.
- A review of post-authorization safety data after administration of 7.98 million doses of Johnson & Johnson/Janssen COVID-19 vaccine during March–April 2021 found that the most commonly reported reactions were similar to those observed in clinical trials and 97% of these events were classified as nonserious. A total of 17 events consistent with cerebral venous sinus thrombosis (CVST) and 3 events of non-CVST thrombosis events were reported in women <60 years. More.
COVID-19 Literature Surveillance Team, is an affiliated group of medical students, PhDs and physicians keeping up with the latest research on SARS-CoV-2 / COVID-19 by finding the newest articles, reading them, grading their level of evidence and bringing you the bottom line.
Read the latest report: April 30 | Weekly COVID-19 LST Report.
Tweet of the Week
"An ethic of solidarity has been glaringly absent" from vaccine-distribution efforts to date, says lead author Nancy Jecker @UWbioethics. https://t.co/vYAI4ckfwJ @profjecker @atuire #COVID19 @UniofGhana @UWPhilosophy
— UW Medicine Newsroom (@uwmnewsroom) May 3, 2021
